These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22877433)

  • 1. Male osteoporosis.
    Drake MT; Khosla S
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):629-41. PubMed ID: 22877433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathophysiology and Treatment of Osteoporosis.
    Drake MT; Clarke BL; Lewiecki EM
    Clin Ther; 2015 Aug; 37(8):1837-50. PubMed ID: 26163201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data from extension trials: denosumab and zoledronic acid.
    Dore RK
    Curr Osteoporos Rep; 2012 Mar; 10(1):16-21. PubMed ID: 22086442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year in review 2018: progress in osteoporosis treatment.
    Figliomeni A; Signorini V; Mazzantini M
    Clin Exp Rheumatol; 2018; 36(6):948-958. PubMed ID: 30526765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiopathogenesis and treatment of osteoporosis and fractures in adult males].
    Martínez Díaz-Guerra G; Guadalix Iglesias S; Hawkins Carranza F
    Med Clin (Barc); 2011 Nov; 137(14):656-62. PubMed ID: 21420694
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson's disease and osteoporosis.
    van den Bos F; Speelman AD; Samson M; Munneke M; Bloem BR; Verhaar HJ
    Age Ageing; 2013 Mar; 42(2):156-62. PubMed ID: 23132148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.
    Adler RA; Hastings FW; Petkov VI
    Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [[Antiresorptive agents in the treatment of osteoporosis].
    Novak S
    Reumatizam; 2014; 61(2):89-94. PubMed ID: 25427401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male osteoporosis: do sex steroids really benefit bone health in men?
    Hoppé E; Morel G; Biver E; Borg S; Chopin F; Legrand E
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S191-6. PubMed ID: 22153669
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of osteoporosis in older adults.
    Diab DL; Watts NB
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):305-17. PubMed ID: 23702403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs.
    Hak DJ
    Injury; 2018 Aug; 49(8):1461-1465. PubMed ID: 29709376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone and glucocorticoids.
    Briot K
    Ann Endocrinol (Paris); 2018 Jun; 79(3):115-118. PubMed ID: 29685453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of bone fragility in diabetes: an emerging challenge.
    Ferrari SL; Abrahamsen B; Napoli N; Akesson K; Chandran M; Eastell R; El-Hajj Fuleihan G; Josse R; Kendler DL; Kraenzlin M; Suzuki A; Pierroz DD; Schwartz AV; Leslie WD;
    Osteoporos Int; 2018 Dec; 29(12):2585-2596. PubMed ID: 30066131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteoporosis and increased risk of fractures].
    Krul-Poel YHM; Vrijlandt PJWS; Elders PJM; van den Bergh JP; Lems WF; de Jongh RT
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male osteoporosis: who should be treated and how?
    Biver E; Borg S; Chopin F; Hoppé E; Morel G; Cortet B
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S202-7. PubMed ID: 22153671
    [No Abstract]   [Full Text] [Related]  

  • 18. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.
    Chiodini I; Falchetti A; Merlotti D; Eller Vainicher C; Gennari L
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):283-298. PubMed ID: 32584619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis.
    Barake M; Arabi A; Nakhoul N; El-Hajj Fuleihan G; El Ghandour S; Klibanski A; Tritos NA
    Endocrine; 2018 Jan; 59(1):39-49. PubMed ID: 29030774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment.
    Féron JM; Mauprivez R
    Injury; 2016 Jan; 47 Suppl 1():S10-4. PubMed ID: 26768282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.